After completing your online medical intake, a licensed provider will review your unique health history, symptoms, and goals to determine if treatmentor a combination of treatmentsis appropriate for you
The phenotypic outcome is a shift toward higher energy expenditure and improved adipose/lipid profiles without the catabolic loss of lean tissue commonly seen with severe caloric restriction
Liu, K., Guo, L., Zhou, Z., Pan, M., & Yan, C
The promise is real, but clinical readiness is not: Preclinical and early human data are compelling, but without large-scale trials, validated delivery methods, and long-term safety data, Epitalon remains an experimental peptide, one to watch closely, but not yet ready for mainstream clinical adoption
Adding TB-500, KPV, or other peptides increases compounding costs and protocol complexity
Verified for identity